Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Clin Med ; 11(23)2022 Nov 23.
Article in English | MEDLINE | ID: mdl-36498485

ABSTRACT

The effectiveness of a universal adhesive applied in different application modes for the preparation of Class V composite restorations was evaluated both clinically and by quantitative marginal analysis (QMA). In each of the 22 patients, four non-carious cervical lesions (NCCL) were restored with Filtek™ Supreme XTE (3M). The adhesive Scotchbond™ Universal (SBU, 3M) was applied in self-etch (SE), selective-enamel-etch (SEE) or etch-and-rinse (ER) modes. The etch-and-rinse adhesive OptiBond™ FL (OFL, Kerr) served as a control. The restorations were clinically evaluated (FDI criteria) after 14 days (BL), 6, 12, 24, and 36 months. Additionally, QMA was conducted on all restorations of 11 randomly selected patients. The FDI criteria and marginal gap were statistically compared between the groups at each recall as well as for the time periods between recalls. The cumulative failure rate was non-significantly higher in the OFL group when compared to all of the SBU groups. Marginal adaptation in the OFL and SBU-SE/ER groups was significantly decreased (BL-36 m, p: 0.004) in comparison to the SBU-SEE group (BL-36 m, p: 0.063). More marginal gaps were found in the OFL group than in the SBU-SEE (BL to 36 m, p: 0.063-0.003) and SBU-ER (24/36 m, p: 0.066/0.005) groups as well as in the SBU-SE group when compared to the SBU-SEE (12-36 m, pi ≤ 0.016) and SBU-ER (24/36 m, p: 0.055/0.001) groups. SBU-SEE performed most effectively. The clinical evaluation and QMA corresponded, yet QMA detected group differences earliest after 6 months and is thus a valuable extension to clinical evaluations.

2.
J Telemed Telecare ; 25(5): 301-309, 2019 Jun.
Article in English | MEDLINE | ID: mdl-29448879

ABSTRACT

PURPOSE: Using a mixed-methods formative evaluation, the purpose of this study was to provide a broad overview of the Alabama eHealth programme set-up and initial patient outcomes. The Alabama eHealth programme uses telemedicine to provide medical care to people living with HIV in rural Alabama. It was led by a community-based organisation, Medical Advocacy and Outreach (MAO), and supported by AIDS United and the Corporation for National Community Service's Social Innovation Fund with matching support from non-federal donors. METHODS: We conducted and transcribed in-depth interviews with Alabama eHealth staff and then performed directed content analysis. We also tracked patients' ( n = 240) appointment attendance, CD4 counts, and viral loads. FINDINGS: Staff described the steps taken to establish the programme, associated challenges (e.g., costly, inadequate broadband in rural areas), and technology enabling this programme (electronic medical records, telemedicine equipment). Of all enrolled patients, 76% were retained in care, 88% had antiretroviral therapy and 75% had a suppressed viral load. Among patients without missing data, 96% were retained in care, 97% used antiretroviral therapy and 93% had suppressed viral loads. There were no statistically significant demographic differences between those with and without missing data. CONCLUSIONS: Patients enrolled in a telemedicine programme evaluation successfully moved through the HIV continuum of care.


Subject(s)
HIV Infections/therapy , Health Services Accessibility/organization & administration , Rural Health Services/organization & administration , Telemedicine/organization & administration , Adolescent , Adult , Alabama , Anti-Retroviral Agents/therapeutic use , Electronic Health Records , Female , HIV Infections/drug therapy , Health Services Accessibility/economics , Humans , Male , Middle Aged , Rural Health Services/economics , Socioeconomic Factors , Viral Load , Young Adult
3.
AIDS Behav ; 22(11): 3734-3741, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29302844

ABSTRACT

Linkage to HIV medical care and on-going engagement in HIV medical care are vital for ending the HIV epidemic. However, little is known about the cost-utility of HIV linkage, re-engagement and retention (LRC) in care programs. This paper presents the cost-utility analysis of Access to Care, a national HIV LRC program. Using standard methods from the US Panel on Cost-Effectiveness in Health and Medicine, we calculated the cost-utility ratio. Seven Access to Care programs were cost-effective and two were cost-saving. This study adds to a small but growing body of evidence to support the cost-effectiveness of LRC programs.


Subject(s)
Anti-HIV Agents/economics , Community Health Services/economics , Continuity of Patient Care/economics , Cost-Benefit Analysis/economics , HIV Infections/drug therapy , Health Care Costs/statistics & numerical data , Health Services Accessibility/economics , Anti-HIV Agents/therapeutic use , Cost-Benefit Analysis/methods , Epidemics , HIV Infections/economics , HIV Infections/epidemiology , Humans , United States
4.
AIDS Educ Prev ; 29(5): 443-456, 2017 Oct.
Article in English | MEDLINE | ID: mdl-29068718

ABSTRACT

The 2020 National HIV AIDS Strategy (NHAS) sets a target of 90% of diagnosed people living with HIV (PLWH) retained in HIV care. Access to Care (A2C) was a national HIV linkage, re-engagement, and retention in care program funded by AIDS United with support from the Corporation for National and Community Service that aimed to link and retain the most vulnerable PLWH into high-quality HIV care. This study explores the barriers and facilitators of implementing the A2C program from the perspective of program staff. Ninety-eight qualitative interviews were conducted with staff at implementing organizations over the 5 years of the project. Barriers included challenges with recruiting and retaining participants, staffing and administration, harmonizing partnerships, and addressing the basic and psychosocial needs of participants. Facilitators included strong relationships with partner organizations, flexible program models, and the passion and dedication of staff. Findings will inform the development of future programs and policy.


Subject(s)
Anti-HIV Agents/therapeutic use , Continuity of Patient Care , Cooperative Behavior , Delivery of Health Care/organization & administration , HIV Infections/drug therapy , Health Services Accessibility , Patient Acceptance of Health Care , Adult , Female , HIV Infections/diagnosis , HIV Infections/psychology , Humans , Interviews as Topic , Medication Adherence , Qualitative Research , United States
5.
Cell Rep ; 13(2): 337-49, 2015 Oct 13.
Article in English | MEDLINE | ID: mdl-26411685

ABSTRACT

Expression of Pitx2 on the left side of the embryo patterns left-right (LR) organs including the dorsal mesentery (DM), whose asymmetric cell behavior directs gut looping. Despite the importance of organ laterality, chromatin-level regulation of Pitx2 remains undefined. Here, we show that genes immediately neighboring Pitx2 in chicken and mouse, including a long noncoding RNA (Pitx2 locus-asymmetric regulated RNA or Playrr), are expressed on the right side and repressed by Pitx2. CRISPR/Cas9 genome editing of Playrr, 3D fluorescent in situ hybridization (FISH), and variations of chromatin conformation capture (3C) demonstrate that mutual antagonism between Pitx2 and Playrr is coordinated by asymmetric chromatin interactions dependent on Pitx2 and CTCF. We demonstrate that transcriptional and morphological asymmetries driving gut looping are mirrored by chromatin architectural asymmetries at the Pitx2 locus. We propose a model whereby Pitx2 auto-regulation directs chromatin topology to coordinate LR transcription of this locus essential for LR organogenesis.


Subject(s)
Chromatin/genetics , Gene Expression Regulation, Developmental , Homeodomain Proteins/genetics , Intestinal Mucosa/metabolism , RNA, Long Noncoding/genetics , Repressor Proteins/metabolism , Transcription Factors/genetics , Animals , Base Sequence , CCCTC-Binding Factor , Chick Embryo , Chromatin/chemistry , Genetic Loci , Intestines/embryology , Mice , Molecular Sequence Data , Morphogenesis , Repressor Proteins/genetics , Homeobox Protein PITX2
SELECTION OF CITATIONS
SEARCH DETAIL
...